Impact of Duration of Parkinsonism and Antiparkinsonian Drugs on Coagulation Parameters in Patients with Parkinson's Disease.

Ann Indian Acad Neurol · 2024 · PMC11575876 · PMID 39428949

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

did not reach statistical significanceP = 0.08so close (0.05 < p ≤ 0.1)

More number of patients on two or more antiparkinsonian drugs (20%) had fibrinogen levels above the upper limit of 400 mg/dl, compared to those on single antiparkinsonian medication (4.3% of patients), but this did not reach statistical significance ( P = 0.08).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.